EDHF mediates flow-induced dilation in skeletal muscle arterioles of female eNOS-KO mice
- 1 June 2001
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 280 (6) , H2462-H2469
- https://doi.org/10.1152/ajpheart.2001.280.6.h2462
Abstract
Vasodilation to increases in flow was studied in isolated gracilis muscle arterioles of female endothelial nitric oxide synthase (eNOS)-knockout (KO) and female wild-type (WT) mice. Dilation to flow (0–10 μl/min) was similar in the two groups, yet calculated wall shear stress was significantly greater in arterioles of eNOS-KO than in arterioles of WT mice. Indomethacin, which inhibited flow-induced dilation in vessels of WT mice by ∼40%, did not affect the responses of eNOS-KO mice, whereas miconazole and 6-(2-proparglyoxyphenyl)hexanoic acid (PPOH) abolished the responses. Basal release of epoxyeicosatrienonic acids from arterioles was inhibited by PPOH. Iberiotoxin eliminated flow-induced dilation in arterioles of eNOS-KO mice but had no effect on arterioles of WT mice. In WT mice, neither Nω-nitro-l-arginine methyl ester nor miconazole alone affected flow-induced dilation. Combination of both inhibitors inhibited the responses by ∼50%. 1 H-[1,2,4]oxadiazolo[4,3- a]quinoxalin-1-one (ODQ) alone inhibited flow-induced dilation by ∼49%. ODQ + indomethacin eliminated the responses. Thus, in arterioles of female WT mice, nitric oxide and prostaglandins mediate flow-induced dilation. When eNOS is inhibited, endothelium-derived hyperpolarizing factor substitutes for nitric oxide. In female eNOS-KO mice, metabolites of cytochrome P-450, via activation of large-conductance Ca2+-activated K+channels of smooth muscle, mediate entirely the arteriolar dilation to flow.Keywords
This publication has 34 references indexed in Scilit:
- Increased Acetylcholine-Induced Vasodilation in Pregnant RatsHypertension, 1999
- Proinflammatory Mediators Chronically Downregulate the Formation of the Endothelium-Derived Hyperpolarizing Factor in Arteries Via a Nitric Oxide/Cyclic GMP–Dependent MechanismCirculation, 1999
- Inhibition of the production of endothelium‐derived hyperpolarizing factor by cannabinoid receptor agonistsBritish Journal of Pharmacology, 1999
- Inhibition of endothelium‐dependent hyperpolarization by endothelial prostanoids in guinea‐pig coronary arteryBritish Journal of Pharmacology, 1999
- Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: an important role for endothelium‐derived hyperpolarizing factor (EDHF)British Journal of Pharmacology, 1998
- Sex differences in the relative contributions of nitric oxide and EDHF to agonist‐stimulated endothelium‐dependent relaxations in the rat isolated mesenteric arterial bedBritish Journal of Pharmacology, 1998
- Endothelium-derived hyperpolarizing factor(s): updating the unknownTrends in Pharmacological Sciences, 1997
- Molecular Characterization of an Arachidonic Acid Epoxygenase in Rat Brain AstrocytesStroke, 1996
- Role of Cytochrome P-450 Enzymes and Metabolites of Arachidonic Acid in the Control of Vascular ToneJournal of Vascular Research, 1995
- Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscleJournal of Cellular Physiology, 1979